Clinical Trial Update: Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sulforaphane in a New Jersey population with autism; sponsored by Rutgers, The State University of New Jersey, the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Autism, Autistic Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING